Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003

NCT00405873 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

73

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: AMT2003

Sponsor

Auron Healthcare GmbH